THC Global Group announces an update on the company's current progress in a letter sent to shareholders earlier today.
The CEO of THC Global Group Limited , Ken Charteris, sent out a letter to the Company's shareholders today. To access the full letter click here.
Medicinal Cannabis Production Commenced – To Support +250,000 Australian Patients
THC Global now operating the largest bio-floral extraction facility in the Southern Hemisphere. Harvesting commenced at Bundy Facility to bring cannabis plant material to Southport Facility.
Cannabis cultivation program using proprietary strains and tissue culturing techniques to ensure genetic consistency and enable rapid multiplication for fast build out of plant material supply Eden Farms Cultivation Project to support cultivation of additional 1,000,000 plants per year at low cost with minimal capex and lead time to commence operations.
Capacity to support over 250,000 Australian patients with Australian produced medicines as well as being an exporter into the global cannabis market Commercial production of 'Canndeo' branded medicines at Southport Facility from early 2020
Increasing CBD Product Sales in New Zealand
Additional stock now reordered following sale of entire recent shipment in New ZealandSimplified prescription process in New Zealand allowing for broader patient availabilityStrong results with imported product indicating likely strong sales once THC Global's product is exported into New Zealand next year .
Canadian Operations – Strong Revenue Growth Performance
Over $3 million unaudited trading revenue for 9 months to Q3 2019 from hydroponics businessLaunching new products and a service offering – expanding revenue base to a potential $5 million in trading revenue for 2020.
Disclaimer: Past performance is not an indicator of future performance.
Disclaimer: past performance is not an indicator of future performance
& Keep Up to Date
Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!